IDEXX Laboratories Surpasses Q4 Earnings and Revenue Expectations
IDEXX Laboratories reported strong Q4 and full-year 2025 results, beating EPS and revenue estimates, driven by growth in its Companion Animal Group diagnostics. Despite strong financial performance and positive 2026 guidance, the stock saw a slight premarket dip, potentially reflecting high investor expectations. The company highlights continued strength in pet health services and effective cost management.
https://mlq.ai/news/idexx-laboratories-surpasses-q4-earnings-and-revenue-expectations/